Back

In an upcoming Peer Exchange experts in cardiology will discuss novel treatment approaches for obstructive hypertrophic cardiomyopathy.

Expert Guidance on Novel Treatment Approaches in Obstructive Hypertrophic Cardiomyopathy

Episodes

Specialty:

All

Year:

All

EP. 1: The Pathophysiology of Obstructive Hypertrophic Cardiomyopathy (oHCM)

ByAnjali Owens, MD,Andrew Wang, MD,James Januzzi, MD,Michelle M. Kittleson, MD, PhD,Milind Desai, MD, MBA

August 17th 2023

Andrew Wang, MD, outlines the epidemiology of obstructive hypertrophic cardiomyopathy (oHCM), and Milind Desai, MD, MBA, reviews the etiology of the condition.

EP. 2: Signs and Symptoms of oHCM

ByAnjali Owens, MD,Andrew Wang, MD,James Januzzi, MD,Michelle M. Kittleson, MD, PhD,Milind Desai, MD, MBA

August 17th 2023

Michelle M. Kittleson, MD, PhD, and James Januzzi, MD, review signs that point to oHCM, highlighting family history and details on the diagnostic evaluation.

EP. 3: Impact of Diagnosis of oHCM

ByAnjali Owens, MD,Andrew Wang, MD,James Januzzi, MD,Michelle M. Kittleson, MD, PhD,Milind Desai, MD, MBA

August 24th 2023

Cardiology experts discuss the importance of an accurate and prompt diagnosis of oHCM, as well as effectively educating the patient about the condition.

EP. 4: Risk Stratification in oHCM

ByAnjali Owens, MD,Andrew Wang, MD,James Januzzi, MD,Michelle M. Kittleson, MD, PhD,Milind Desai, MD, MBA

August 24th 2023

Milind Desai, MD, MBA, comments on risk stratification for sudden cardiac death (SCD) in oHCM.

EP. 5: Approaches to Imaging in oHCM

ByAnjali Owens, MD,Andrew Wang, MD,James Januzzi, MD,Michelle M. Kittleson, MD, PhD,Milind Desai, MD, MBA

August 31st 2023

Milind Desai, MD, MBA, leads a discussion on the importance of accurate imaging in oHCM and aortic stenosis, highlighting the echocardiogram and doppler tests.

EP. 6: Goals of Treatment in Symptomatic oHCM

ByAnjali Owens, MD,Andrew Wang, MD,James Januzzi, MD,Michelle M. Kittleson, MD, PhD,Milind Desai, MD, MBA

August 31st 2023

Expert cardiologists discuss treating patients with symptomatic vs asymptomatic oHCM.

EP. 7: Guideline-Directed Therapy in oHCM

ByAnjali Owens, MD,Andrew Wang, MD,James Januzzi, MD,Michelle M. Kittleson, MD, PhD,Milind Desai, MD, MBA

September 7th 2023

Andrew Wang, MD, comments on the treatment algorithm for symptomatic oHCM, highlighting treatment guidelines, and James Januzzi, MD, reviews treatment selection for oHCM through the lens of the patient’s quality of life.

EP. 8: Septal Reduction Therapies in oHCM

ByAnjali Owens, MD,Andrew Wang, MD,James Januzzi, MD,Michelle M. Kittleson, MD, PhD,Seemal R. Desai, MD

September 7th 2023

Expert cardiologists share approaches to the challenges that come with septal reduction therapy, as well as access to oHCM treatment.

EP. 9: Advances in oHCM Therapy

ByAnjali Owens, MD,Andrew Wang, MD,James Januzzi, MD,Michelle M. Kittleson, MD, PhD,Seemal R. Desai, MD

September 14th 2023

Milind Desai, MD, MBA, comments on the broadening knowledge in the oHCM space, leading to the development of new therapies.

EP. 10: Use of Cardiac Myosin Inhibitors (CMI) in oHCM

ByAnjali Owens, MD,Andrew Wang, MD,James Januzzi, MD,Michelle M. Kittleson, MD, PhD,Milind Desai, MD, MBA

September 14th 2023

Andrew Wang, MD, discusses the use of cardiac myosin inhibitors (CMIs) as a new, less invasive option for treating oHCM.

EP. 11: Clinical Trials of Mavacamten in oHCM

ByAnjali Owens, MD,Andrew Wang, MD,James Januzzi, MD,Michelle M. Kittleson, MD, PhD,Milind Desai, MD, MBA

September 21st 2023

Milind Desai, MD, MBA, and Michelle M. Kittleson, MD, PhD, review the clinical trial data of mavacamten, the first FDA-approved cardiac myosin inhibitor for the treatment of oHCM.